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Diastolic dysfunctionThe extracellular matrix (ECM) is a major component of the biomechanical environment with which cells
interact, and it plays important roles in both normal development and disease progression. Mechanical and bio-
chemical factors alter the biomechanical properties of tissues by driving cellular remodeling of the ECM. This re-
view provides an overview of the structural, compositional, and mechanical properties of the ECM that instruct
cell behaviors. Case studies are reviewed that highlight mechanotransduction in the context of two distinct
tissues: tendons and the heart. Although these two tissues demonstrate differences in relative cell–ECM compo-
sition and mechanical environment, they share similar mechanisms underlying ECM dysfunction and cell
mechanotransduction. Together, these topics provide a framework for a fundamental understanding of the
ECM and how it may vary across normal and diseased tissues in response to mechanical and biochemical cues.
This article is part of a Special Issue entitled: Mechanobiology.
© 2015 Published by Elsevier B.V.1. Introduction
1.1. Mechanical properties of the extracellularmatrix instruct cell behaviors
The local microenvironment of cells plays important roles in both
normal development and disease progression. A major component of
the biomechanical environment of cells is the dense meshwork of
ﬁbrous proteins and other biopolymers called the extracellular matrix
(ECM). This intricate biomaterial provides structural support for many
tissues in vivo and provides cells with mechanical cues that modulate
both cell morphology and physiology. Numerous cell types possess
ATP-driven molecular machinery that applies forces and responds to
the ECM.
Cell responses to the ECM are driven by intrinsic properties that
include adhesive afﬁnity, matrix stiffness, ﬁber alignment, and matrix
density [1]. In mature tissues, cell adhesion to the ECM is primarily,
but not exclusively, mediated by integrins, which are transmembraneobiology.
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this manuscript.heterodimeric receptors that interact with a range of ECM components
and cluster into different kinds of adhesion sites with an array of intra-
cellular components [2–4]. Integrins interact with the force-producing
actin cytoskeleton, where changes in force alter the assembly of adhe-
sion complexes and activate adhesion-mediated cell signaling, such as
RhoA-induced actin stress ﬁber formation (Fig. 1) [5,6]. Integrin type
and density determine the cell adhesion afﬁnity for, and mechanical
sensing of, the ECM [3,7,8]. The most commonly studied ECM mechan-
ical properties are substrate stiffness (a structural property) and elastic
modulus (a material property) (Table 1) [4,5,9]. Cells sense substrate
stiffness primarily via integrin-dependent actomyosin contraction
(Fig. 1). Human tissues have various collagen compositions and a wide
range of moduli varying from 100 Pa in brain tissue to over 1 MPa in
bone (Fig. 2A, B) [10,11]. Substrate stiffness has been shown to guide
stem cell lineage speciﬁcation in vitro and affect proliferation, motility,
contractility, and many other cell functions by changing both acute
signaling and transcriptional programs [12–14]. Fiber orientation in
the matrix is also critical for various cell behaviors, including stem cell
differentiation [15], cell alignment [16–18], and migration [19].
In cell-dense tissues such as the heart, cells are bound together by
adherens junctions, and mechanotransduction occurs via calcium-
dependent transmembrane proteins (termed cadherins) (Fig. 1) [20,
21]. Much like integrins, cadherins form complex adhesions, connect
to the actin cytoskeleton via numerous proteins including catenins,
Fig. 1.Model of cell–ECM and cell-cell mechanotransduction. Cells sense ECM stiffness and external loading by balancing the force between the actomyosin machinery and integrin ad-
hesions. Important molecules involved in the generation of cytoskeletal tension include F-actin, myosin, and the Rho signaling cascade. It is noted that this illustration highlights only the
basic subunits of these adhesion complexes, and that these components come together into higher order assemblies in vivo.
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both cell–ECM and cell–cell contacts play important roles in the detec-
tion of tissue mechanical properties.
1.2. Effects of internal and external mechanical stimuli on cell responses
Cell- and environment-generated mechanical loads on the ECM can
induce a variety of cell responses (Fig. 1). The types of stimuli include ten-
sile, compressive, and shear stresses and strains (Table 1). Transformation
of internal and externalmechanical cues into cellular responses occurs via
collagen ﬁber kinematics [24], focal adhesions (macromolecular assem-
blies of integrins and proteoglycans) [25], and cell–cell contacts [20,22,
23,18]. An internal source of ECM loading is cell traction force. Cells
achieve tensional homeostasis with their ECM by balancing traction
forces withmatrix stiffness [26–28]. Maintenance of tensional homeosta-
sis plays an important role in the regulation of critical cell functions. For
example, during wound healing, ﬁbroblasts reorganize the collagen
matrix by exerting traction forces [18]. The increased stresses within the
ECM cause the cells to generate a stiffer matrix by producing collagen,
become more contractile in response to the increased stiffness, and
differentiate into myoﬁbroblasts that propagate this feedback loop and
ultimately contract the wound [29]. Normally, this positive feedback iscountered by other signals that limit the extent of contraction and
matrix deposition, but when left unchecked can lead to scar formation
and other tissue defects. Forces transferred through the ECM have a
wide range of magnitudes. Although macroscale orthopaedic tissues
may experience up to 3500N of loading [30,31], cell–ECM force interac-
tions are nearly 12 orders of magnitude smaller (nN) (e.g., [32]), and
subcellular interactions betweenmyosin and actin crossbridges can bal-
ance forces of less than 1 pN [33].
Cells remodel the ECM in response to external mechanical signals as
well as the biomechanical properties of the matrix [34–40]. Through
tensional homeostasis, cells demonstrate reduced cell-mediated
contraction with increased externally applied loads [26]. External
stress- and strain-induced changes in cell behavior have been exten-
sively studied in tissue injury. For example, acute mechanical compres-
sion of articular cartilage enhances chondrocyte proliferation and
decreases proteoglycan synthesis [35]. Also, the production of various
ECM components by cardiac ﬁbroblasts in response to cyclic loads is
implicated in pathological ﬁbrosis of the heart [36]. Fluid ﬂow through
the ECM can also signiﬁcantly impact cell behaviors [37–40]. For
example, interstitial ﬂuid ﬂow has been demonstrated to regulate
ﬁbroblast alignment and lymphatic and vascular endothelial functions
in three-dimensional cell cultures [39–41].
Table 1
Engineering terms and deﬁnitions.
Term Deﬁnition
Stress (σ) Force (F) applied over an area (A), either perpendicular (e.g., pulling (tensile) and pushing (compressive)) or parallel (shear) to the material's axis; σ= F / Α
Ultimate stress Maximum stress before material failure
Strain (ε) Unitless parameter quantifying the extent of deformation after application of stress. Strains are also categorized as tensile, compressive, or shear.
Principal strain Maximum or minimum strain along the direction of zero shear strains
Strain stiffening Increase in elastic modulus with applied strain
Stiffness (k) Rigidity of a material deﬁned as force (F) per resultant displacement (δ) (structural property); k = F / δ
Elasticity Material property characterizing the ability of a deformed material to recover completely to its original state when the force is removed
Elastic modulus (E) Resistance of a material to elastic deformation, measured by the ratio of stress and strain (material property); For linearly elastic materials, E = σ / ε
Viscoelastic Combination of viscous and elastic mechanical properties. Viscosity refers to the resistance of ﬂuid to ﬂow, measured by the ratio of stress to the rate of
strain or ﬂow rate.
Poroelastic Property of a porous material consisting of an elastic solid matrix and viscous ﬂuid in which mechanical relaxations arise from ﬂuid ﬂow through the matrix.
3155B.R. Freedman et al. / Biochimica et Biophysica Acta 1853 (2015) 3153–31641.3. Mechanotransduction in the context of diseases and injury
Alterations in ECM composition, stiffness, and loading environment
affect cell behaviors, which feed back to ECM dysregulation and disease
progression. For example, in pulmonary and cardiac ﬁbrosis, enhanced
myoﬁbroblast proliferation and collagen production increase tissue
stiffness (Fig. 2C) [42–44]. In addition, abnormal mechanical stimula-
tion can aberrantly activate signaling pathways, such as TGF-β signaling
associated with osteoarthritis [45] and β-catenin signaling in cancer
progression (Table 2) [46]. In light of these examples, it is importantFig. 2. Tissue stiffness and its relationship to collagen content. (A) Tissues exhibit a wide
range of stiffnesses as measured by the elastic modulus. (B) Tissue stiffness relates to
the quantity of type I collagen. As the most prevalent protein in many tissues, collagen
modulates mechanical properties of tissue. (C) Hematoxylin and eosin staining shows in-
creasing severity of cardiac ﬁbrosis with elevated collagen content (arrows) between
muscle ﬁbers (red), leading to tissue stiffening. Panel A: Reproduced with permission
from Janmey andMiller [11]. Panel B: Reproducedwith permission from Swift andDischer
[10]. Panel C: Reproduced with permission fromWeidemann et al. [44].to understand the underlying mechanism of mechanotransduction in
order to target ECM or cell mechanosensing to ameliorate the disease
condition.
1.4. Overview for the rest of the paper
This review highlights the effects of ECM function and dysfunction
on cellular responses in different tissues. Speciﬁcally, the remainder of
this review examines themusculoskeletal and cardiovascular organ sys-
tems,with a focus on the tendon and the heart ECM.Although these two
tissues demonstrate differences in relative cell–ECM composition and
mechanical environment, they share similar mechanisms underlying
ECM dysfunction and cell mechanotransduction. In each case study,
we discuss the techniques and models used to investigate cell and
ECM responses to injury and disease at tissue, cellular, and molecular
levels.
2. Case study 1: the extracellular matrix in the tendon
2.1. Structure–function relationships in tendon ECM
Tendons connect and transmit forces from muscle to bone [47] and
are composed of tenocytes (tendon ﬁbroblasts) and tendon-derived
stem cells (TSCs) [48]. These cells are embedded in a heterogeneousTable 2
Medical terms and deﬁnitions.
Term Deﬁnition
Angiogenesis Formation of new blood vessels from existing ones
Arterial and venous tissue Tissues pertaining to arteries and veins
Artery and veins Blood vessels that carry blood away from and towards
the heart, respectively
Ejection fraction The fraction of total blood pumped from the heart
with each heartbeat, typically measured by
echocardiogram
Electrophysiology Study of the electrical characteristics of cells and
tissues
Infarction Tissue death caused by a lack of oxygen supply
(hypoxia)
Ischemic cardiomyopathy Inferior ability of the heart to pump blood due to poor
oxygen supply to the myocardium
Myocardium Muscular tissue of the heart
Myocardial/cardiac or
pulmonary ﬁbrosis
Abnormal scarring of the muscular heart and lung
tissues, respectively
Osteoarthritis Degenerative musculoskeletal joint disease affecting
articular cartilage and bone
Overuse High repetitive loading such as labor-intensive work
that may result in injury
Pressure overload Pathological state of cardiac muscle whereby the
heart contracts while experiencing excessive stress
Rotator cuff Group of muscles and tendons that stabilize the
shoulder joint. These include the supraspinatus,
infraspinatus, teres minor, and subscapularis.
Fig. 3. Tendon hierarchical structure and a typical stress-strain curve. (A) Tendons contain tenocytes (tendon ﬁbroblasts) embedded in a hierarchical matrix of collagenous and
noncollagenous components. Tendons are composed of fascicles, ﬁbers, and ﬁbrils that form from collagen molecules. (B) During mechanical loading, tendons exhibit nonlinearity in
their stress strain curve, containing a toe region prior to a transition to a linear region.With increases in stress and strain, collagen ﬁbers uncrimp and re-align. Panels A and B: Reproduced
with permission from Connizzo et al. [201].
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elastin, ﬁbronectin, and ﬂuid (70% wet weight) [51,52]. Together,
these molecules form a hierarchical network from the macro-
(“fascicle”) to nano- (“ﬁbril”) scales (Fig. 3A) [53]. While collagen is
generally thought to be the main mechanical element in tendons,
removal of non-collagenous molecules, such as elastin or glycosamino-
glycans, reduces the whole tendon mechanical response, emphasizing
their role in development, homeostasis, and load transfer [54–56].
Tendons exhibit enormous variation in material properties as they
anatomically originate from muscle (compliant material) and insert
into bone (stiff material). This variation in tendon stiffness changes
based on anatomical location and species [57], as well as the amount
of strain applied [58]. Disorganized ECM becomes more aligned and
less wavy (termed “crimp”) [59] with mechanical loading, giving way
to a distinct “toe-region” or strain stiffening mechanism (Table 1;
Fig. 3B). In addition, tendons are viscoelastic and poroelastic (Table 1),
which results in rate- and time-dependent properties and ﬂuid ﬂow
within the ECM [60], similar to other biological tissues (e.g., cartilage,
bone, liver, heart, and lung).
During normal humanmotion, the stresses and strains that tendons
experience vary based on anatomical position and activity level.
Although many tendons operate in the toe-region of tissue's stress–
strain curve where resistance to deformation begins to increase (less
than 5% of their load until rupture) [61], higher load bearing tendons,
such as the Achilles, can experience forces nearly 70% of theirmaximum
load and stress before rupture (~3500 N or ~55 MPa) [30,31]. The
primary direction of loading in tendons is tensile, yet compressive,
biaxial, and shear stresses may be present [62,63]. The wide variation
in mechanical properties and loading environments across tendons
emphasizes their dynamic role in the musculoskeletal system and the
complexity of research necessary to understand their basicmechanisms
of homeostasis and injury.
2.2. Effects of external and internal mechanical stresses on the ECM and cell
response in tendinopathy
Maintenance of mechanical, structural, and compositional properties
is heavily inﬂuenced by mechanical loading and biochemical factors.
Aberrant mechanical loading [64–68] can cause pathological changesresulting in tendinopathy, a degenerative condition characterized by an
imbalance between degradation and synthesis of the ECM. For example,
rotator cuff (Table 2) tendinopathy affects approximately 4–6% of the
population between the ages of 25–64, with a much higher percentage
in laborers (19%) [64] and athletes, such as elite swimmers (69%) [69,
70]. Tendinopathy can affect several tendons, especially those highly
load bearing including the Achilles [53], patellar [71], and rotator cuff
[72]. Individuals with tendinopathy present with tendon thickening and
increased vascularization, as evaluated with ultrasound [73]. While the
pathogenesis of tendinopathy is poorly understood, it is suggested that
aberrantmechanical stimuli may drive tenocytes and TSCs towards path-
ologic changes [48,74]. Although biochemical mechanisms driving
tendinopathy may be present, we focus on the mechanical mechanisms
at play from whole tendon biomechanics down to the ECM, cellular,
and sub-cellular levels.
2.2.1. The ECM and cell response to in vivo loading in tendinopathy
The effect of in vivo joint loading on the ECM and the corresponding
cell response in the tendon has been evaluated in both humans and
animal models. External loading may generate interstitial pressures
surrounding the tendon, ﬂuid shift, and alterations in blood ﬂow that
activate mechanotransductive pathways [75]. Human studies have
assessed changes in tendon stiffness using ultrasound [76,77], biochem-
ical changes via tissue biopsy (e.g., collagen content and crosslinking)
[78], or serum levels (e.g., TNF-α, IL-10, and CTGF) [79]. Without
loading, tendon structural organization and dynamic elastic and viscous
properties decreased [80], which may have been caused by increased
matrix degradation [81] and increased expression of inﬂammatory
cytokines [82]. In contrast, a single session of activity modulated the
expression of ECM proteins and upstream cell signaling markers [83].
A model of repetitive loading increased tensile modulus (52%), stress
to rupture (69%) [84], and tendon thickness (~9–20%) [85], which
may be due to increased collagen synthesis [84,86]. However, it is
noted that some studies have demonstrated no differences in tendon
material properties following various bouts of moderate, repetitive
loading [87,88], suggesting that the speciﬁc moderate-load protocols
that create an adaptive response are not fully deﬁned.
Excessive loading promoted tendon matrix synthesis through
increased growth factor production, proliferation of TSCs, and
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[89]. Histopathological characterization of tendinopathy in humans
demonstrated altered collagen content, decreased ﬁber organization,
aberrant ECM deposition (calciﬁcation, ossiﬁcation, lipid accumulation),
and accumulation of proteoglycans between degenerated collagen ﬁbers
(i.e., mucoid degeneration) [90]. Rodent models of shoulder overuse
(Table 2) induced similar tendinopathic conditions [91]. Speciﬁcally,
overuse loading in the rat supraspinatus tendon increased inﬂammation,
angiogenesis, the production of cartilage markers and proteoglycans, and
type III/I collagen ratio (Table 2) [92–94]. Similarly, high-cycle fatigue
loading produced a degenerative, microstructural damage response
[95]. In addition to overuse, abnormal loading, such as disuse, compres-
sion or shear from contactwith neighboring structures, or change in load-
ing direction caused by injury can initiate a pathologic response and
contribute to the development of tendinopathy [96]. For example, tendon
impingement is a leading cause of rotator cuff tendinopathy. Additionally,
rotator cuff tears can cause a force imbalance in the shoulder joint, which
results in tendinopathy in adjacent rotator cuff tendons [97–99]. Taken
together, these data suggest that overuse and abnormal loading may
disrupt the homeostatic balance between synthesis and degradation,
creating an overall catabolic response and development of disease.
2.2.2. The ECM and cell response to ex vivo tissue-level loading in
tendinopathy
While in vivo models of tendinopathy provide the most clinically
relevant information about the disease, these models have a limited
ability to evaluate how themechanical loads are transmitted at a small-
er scale, and therefore their mechanistic effects on the cells and ECM.
Thus, alternativemethods apply tensile loads to ex vivo tendon explants
to preserve the native architecture of the ECM, while also providing
more controlled experimental conditions than are possible in vivo.
Experiments on non-living tendon explants have investigated structural
and mechanical alterations that occur to the ECMwith repeated induc-
tion of micro-damage via overloading and fatigue loading models.
When tendons are subjected to high dynamic loading, fatigue damage
accumulation occurs [100] in concert with alterations in crimp proper-
ties [101]. Repeated subrupture loading results in collagen ﬁbril kinking
[102], which can affect cell morphology and matrix degradation [103].
These mechanisms of microdamage accumulation may be tendon type
[104] and age speciﬁc [105].
To further investigate the effects of tissue-level loading on biological
response, in vitro bioreactor model systems are used. Typically, fascicles
derived from tail [106–109], ﬂexor [110], extensor [111], or patellar
tendons [112,113] are cultured in standard media conditions under
various amounts of applied load, duration, and frequency. In vitro stress
deprivation ﬂattened and elongated ﬁbroblasts, decreased cell number,
and decreased tensile modulus [110]. Although low and moderate
loading had no effect on water content [110] or glycosaminoglycan
production [109], higher loading increased glycosaminoglycan content
[114], lowered mechanical strength, and caused the release of pro-
inﬂammatory cytokines and vasodilators, such as prostaglandin E2
(PGE2) and nitric oxide (NO) [115]. Certain loading regimes may
promote optimal mechanical properties [113], potentially through
collagen synthesis [109,111] as the molecular mechanisms switch
from a catabolic to anabolic response [106]. Such mechanisms could
depend on the frequency and duration of the loading [112].
Taken together, these studies suggest that ex vivo loading of tendon
explants provides a controlled method for evaluating the speciﬁc re-
sponse of tendon to loading, thus removing confounding variables pres-
ent in whole tissue model systems. Many of the same mechanical and
biological mechanisms are conserved, demonstrating the validity of
these models.
2.2.3. ECM and cell response to cellular-level loading in tendinopathy
Loading applied directly to cells in vitro can provide more direct
information on the cell level response to mechanical stimuli. Scaffoldsseeded with cells under cyclic strains have been used to investigate
cell behavior in response to loading. Tenocytes isolated from patellar
and Achilles tendons subjected to physiological strain levels upregulat-
ed only tenocyte markers (type I collagen and tenomodulin), whereas
higher levels of strain upregulated biomarkers found in cartilage [89].
Cyclically stretched human patellar tendon ﬁbroblasts responded with
a load-dependent increase in inﬂammatory cytokines, which could
reduce cell proliferation and collagen synthesis and lead to the
development of tendinopathy [116,117]. Over-tensioning TSCs caused
osteogenic differentiation and upregulation of BMP-2 [118,119]. This
response was regulated through the mechanosensitive activation of
RhoA, which plays a role in cell proliferation, differentiation, and adhe-
sion formation [119]. Microﬂuidics and modeling approaches [120,121]
have provided further insight into the response of cells under ﬂuid shear
stresses. Fluid shear stresses have been implicated in gene expression
changes in degradation [122], collagen remodeling [123], anti-ﬁbrosis
[124], ecto-ATPase activity [125], NO production [126], and calcium sig-
naling [127] in the tendon. In addition to the application of ﬂuid shear
stresses to modulate cell behavior, biochemical cues activated by
mechanical stimulation [128,129] might also drive phenotypic behav-
iors. In particular, the effect of cyclic strain has been shown to mirror
that of TGF-β stimulation [130]. Primary tendon ﬁbroblasts treated
with TGF-β demonstrated increased expression ofmiRNAs that regulate
cell proliferation, ECM synthesis, and scleraxis (a tendon marker) [83].
Observed changes in gene expression, cytokine release, and
nontenogenic differentiation following high loading may be due to
upstream mechanosensing in the cytoskeleton. Application of strains
on cells can create an adaptive response to the cytoskeleton and
adherens junctions [131]. Speciﬁcally, N-cadherin and vinculin levels
increased in strained cultures, and cells organized their actin into stress
ﬁbers along the axis of principal strains (Table 1) [131]. In addition,
tenocyte communication via gap junctions may be altered with loading
[132,133]. For example, when tenocytes were subjected to cyclic strain,
their gap junctions became disrupted and apoptosis was induced [134].
Cell–matrix adhesions allow tenocytes to sense and respond to their
mechanical environment while also allowing them to act on the ECM
through actomyosin mediated contractile forces [135]. Altering the ten-
sile forces on tendons can elicit changes in integrin receptors, as well as
in downstream ECM proteins [135]. Speciﬁcally, de-tensioning
tenocytes in vitro caused a decrease in collagen binding integrin
α11β1, which is associated with the organization of collagen in the
ECM, and an increase in collagen binding integrinα2β1 and ﬁbronectin
integrin receptor α5β1, which are associated with the transmission of
cytoskeletal forces through collagen ﬁbrils causing contraction and
adhesion strength, respectively [135]. Additionally, de-tensioning
decreased expression of tenomodulin and Mohawk homeobox, which
are associated with tendon differentiation, as well as decreased
collagens, decorin, and matrix organization and increased pro-
inﬂammatory markers [135]. These results demonstrate that mechani-
cal loading alters mechanosensitive proteins and therefore plays a
large role in the maintenance of a normal tendon phenotype as well
as the development of pathology.
2.3. Summary and future work
Since the primary function of tendons is to transmit forces from
muscle to bone, its ability to adapt and respond to loads is essential to
prevent injury. Previous work has shown the sensitivity of the tendon
to alterations in mechanical stimuli (Fig. 4). Establishing changes in
gene and protein levels following variousmechanical protocols is neces-
sary to conﬁrm that models accurately represent the human condition.
Once these model systems have been optimized, a more mechanistic
evaluation of alterations in the cell and ECM that elicit tendinopathic
responses is necessary.
Animal models can help to elucidate the underlying in vivo mecha-
nisms of tendinopathy in humans, but they have limitations. Although
Fig. 4.Various pathways thatmay result followingmechanical loading in tendon. Low loading decreased tensile strength [80,82,110], collagen organization [80,110], and tenocytemarkers
[135]; net collagen degradation and inﬂammatory cytokines increased [82,135], and GAG content was unchanged [109]. Moderate loading increased tensile strength [84], net collagen
synthesis [83,84,86,109,111], tenogenic differentiation [89], and cross-sectional area [84,85]. Knowledge regarding collagen organization, vascularization, GAG production, and inﬂamma-
tory cytokines with moderate loading remains limited. Excessive loading decreased tensile strength [77,115] and collagen organization [91,95], and increased net collagen degradation
[78,90], aberrant differentiation [89,92–94,118,119], cross-sectional area [73], vascularization [73,91,115], GAG production [114], and inﬂammatory cytokines [79,115].
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plify true in vivo biological complexity. Additional knowledge may be
gained from other, genetically-tractable model systems that focus on
cell–ECM interactions. Drosophila tendon cells have adopted a compact
microtubule [136] and F-actin [137] array as cytoskeletal structures to
withstand high mechanical loads, and may be used to study the
muscle–tendon junction. In addition, zebraﬁsh craniofacial tendons,
which connect cartilage and muscle, contain parallel arrays of collagen
ﬁbrils, suggesting that they are structurally similar to mammalian
tendons. These tendons are derived from neural crest cells, speciﬁed
by muscle-induced expression of tendon-differentiation markers, and
upregulate tenomodulin and type I collagen, as in mammals [138].
Therefore, zebraﬁsh may provide an additional model system for
elucidating mechanisms of tendinopathy.
3. Case study 2: the extracellular matrix in the heart
3.1. Structure–function relationships in the heart ECM
The heart is a muscular pump that circulates blood throughout
the body composed of four major chambers (two atria and two
ventricles), each containing several tissue compartments. First, the
parenchyma is composed of specialized cardiac muscle cells called
cardiomyocytes. These cells are further subdivided into atrial, ven-
tricular, and conductive system cardiomyocytes. Cardiomyocytes are ter-
minally differentiated, non-proliferating, excitable cells, which generate
electrical signals that induce a coordinated contractile behavior allowing
the heart to eject blood into the systemic and pulmonary circulations.
The coronary vasculature represents a second tissue compartment that
comprises arterial and venous tissue (Table 2) and oxygenates and
facilitates removal of waste products. The cardiomyocytes and coronary
vessels are tethered to an ECMcomprising the endomysium, perimysium,
and epimysium,which surround themyoﬁbers and coronary vessels. The
main component of the heart ECM is ﬁbrillar type I collagen,with types III
and V contributing 10–15% and b5%, respectively [139]; proteoglycans
and glycoproteins are also present. Cardiac ﬁbroblasts reside in the ECM
and form the largest population of cells in the heart (two-thirds)whereas
cardiomyocytes occupy two-thirds of the total tissue volume [140].
Further, these ﬁbroblasts mediate a constant homeostatic state of
synthesis and degradation of ECM.During pumping, the heart undergoes continuous cycles of systole
and diastole. Systole involves muscular contraction and the ejection of
blood into the systemic and pulmonary circulations, whereas diastole
involves relaxation and ﬁlling of the left and right ventricles (LV, RV)
[141]. The heart ECM contributes to contractility, compliance,
relaxation, and electrophysiology (Table 2). During stress states
(e.g., hypoxia/infarction and pressure overload), ﬁbroblasts adopt a
phenotypic change into alpha smooth muscle actin- (α-SMA) positive
myoﬁbroblasts (activated ﬁbroblasts able to promote ECM overexpan-
sion) (Table 2). The interactions among the cardiomyocytes, ﬁbroblasts,
coronary vasculature, and ECM provide the structure necessary for me-
diating biomechanical cross talk, mechanotransduction, and the devel-
opment of cardiac stress, stretch, and stiffness (Fig. 5) [139,142].
3.2. Introduction to heart failure pathophysiology
Abnormalities in heart biomechanics cause several common and
highly morbid cardiovascular diseases including heart failure (HF),
which is associated with 50% mortality at 5 years following diagnosis
[143]. Aberrant changes in the cellular and ECM compartments of the
myocardium (Table 2) lead to increases in tissue and cellular stiffness
and wall stress [142,144–148]. These changes induce systolic and/or
diastolic dysfunction, which has been strongly associated with the
development of HF [149,150].
HF is a pathophysiological state mediated by myocardial (systolic
and diastolic dysfunction) and extramyocardial (e.g. vascular stiffness,
endothelial dysfunction, skeletal muscle metabolic derangements)
abnormalities that either (1) undermine the ability of the heart to
pump sufﬁcient blood to meet the body's metabolic demands, or
(2) allow it to meet these demands only when ventricular ﬁlling
pressures are signiﬁcantly elevated as a result of increased chamber
stiffness and slowed active relaxation [141,151,152]. Two major
subtypes of the HF syndrome are HF with reduced ejection fraction
(HFrEF) (i.e., systolic dysfunction) and HF with preserved ejection
fraction (HFpEF) (i.e., diastolic dysfunction) (Table 2) [153]. Although
therapies targeting systolic dysfunction have improved the outcomes
of many subjects with HFrEF [143,154], no therapeutic interventions
in theHFpEF population have improved clinical outcomes. Furthermore,
diastolic dysfunction is usually present in patients with HFrEF, and
subclinical abnormalities in systolic function (detected non-invasively
Fig. 5. Feedbackmechanisms of loading on cell–ECM, cell–cell, and intracellular proteins that regulate cytoskeletal architecture, remodeling, and functional response. Myocardial remod-
eling represents changes in the cell (ﬁbroblasts and cardiomyocyte) and ECM compartments of the heart in response to physiologic (e.g., endurance exercise) and pathologic
(e.g., ischemia, infarction, infection, inﬁltration, and hypertension) stimuli. This leads to changes in cardiac biomechanics (stiffness), electrophysiology, and function (systole and diastole).
Adverse myocardial remodeling represents a major mechanism and endpoint leading to the development of HF. HFrEF — Heart Failure with Reduced Ejection Fraction, HFpEF — Heart
Failure with Preserved Ejection Fraction.
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HFpEF.3.3. Effects of HF on ECM remodeling and biomechanics
Abnormal diastolic biomechanics play a central role in the patho-
physiology of HF. Severity of abnormalities correlates with worsening
clinical outcomes. Furthermore, even the presence of abnormal diastolic
biomechanics in asymptomatic individuals associates with a higher risk
of developingHF, underscoring the importance of biomechanics in heart
function [143,152,155–160].
Although these echocardiography-based studies introduced the
concepts of abnormal diastolic biomechanics (e.g., slowed relaxation, in-
creased stiffness, increased ﬁlling pressures), the mechanistic basis for
these abnormalities (in humans) remained elusive until the advent of
magnetic resonance imaging (MRI) to noninvasively characterize
cardiac tissue properties in humans. In vivo cardiac MRI measures of
myocardial ﬁbrosis (Table 2) have demonstrated that expansion of the
ECM compartment is associated with increased risk of sudden cardiac
death, HF, mortality, and preclinical myocardial dysfunction [161–163].
Furthermore, increased ﬁbrosis in HFpEF patients correlates with
worse clinical outcomes [164]. In vivomeasures of both focal and diffuse
myocardialﬁbrosis have been strongly associatedwithmajor cardiac dis-
ease states and clinical events [165]. Remodeling in both the ECMand the
cardiomyocyte myocardial compartments including ﬁbrosis, deposition
of advanced glycosylation end products, cardiomyocyte hypertrophy,
myocardial thickening, and increased stiffness has been conﬁrmed in
myocardial tissue from humans with HFpEF and HFrEF [166–168].
Studies examining tissue-level rheology have also demonstrated
increased stiffness of myocardial tissue in pathological stress states.
Increased elastic modulus of infarcted versus non-infarcted tissue and
the border zone myocardium were found in a rat model of ischemic
cardiomyopathy (Table 2). Increased stiffness was also observed in the
peri-infarct zone in a mouse infarction model [169]. The extension of
adverse biomechanical remodeling beyond the infarct zone is well
known to be central to the development of HF. Furthermore, tissuerheological changes occur in the presence of increased ﬁbrosis and
correlate to in vivo measures of systolic and diastolic dysfunction [170].
Changes in the cardiomyocyte compartments, in addition to the
ECM, can also lead to abnormal global cardiac biomechanics, function
(systolic and diastolic), and HF. Reduced cardiac strain assessed with
echocardiography correlated with cardiomyocyte stiffening, disorgani-
zation of T-tubule structure, and abnormalities in intracellular calcium
handling in a hypertensive rat model [171]. Interestingly, adverse
cardiomyocyte remodeling preceded increased ECM stiffness in the
transition from hypertensive heart disease to HF. This demonstrates
that one source of increased stiffness may originate from the cardio-
myocyte tissue compartment.
In summary, these strong associations of diastolic dysfunction, ECM,
and cardiomyocyte remodelingwith cardiovascular events and death in
humans with HF underscore the importance of biomechanical
derangements in human cardiovascular diseases. The potential molecu-
lar mechanisms mediating increased cardiomyocyte stiffness are
addressed in the next section.
3.4. Cellular and molecular mechanisms underlying cardiac
mechanotransduction and mechanics
The molecular composition of the ECM impacts the stiffness of
cardiomyocytes, as demonstrated in in vitro cultures of cardiomyocytes
on different matrices [172]. Integrins, hyaluronic acid content, and
matrix stiffness are suggested to be tightly regulated for normal develop-
ment of structure and function of cardiomyocytes, highlighting the
importance of ECM remodeling and regulation in development [173].
The importance of cell–matrix interactions in the heart and of integrin-
mediated matrix stiffness sensing by cardiomyocytes has also been
demonstrated. Integrin-mediated (i.e., ﬁbronectin–cardiomyocyte)
interactions are critical for mediating normal ventricular contraction
and relaxation [174]. The costamere, which couples the sarcomere
(basic unit of muscle) with the sarcolemma (cell membrane of a striated
muscle ﬁber cell), contains integrins that connect to the Z-disk (line
forming sarcomere boundaries) and cytoskeleton via proteins including
talin, vinculin, desmin, FAK, and α-actinin [175]. This forms the
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between the cardiomyocyte and its surrounding matrix. In one study,
ﬁbronectin–integrin adhesion force and adhesion probability increased
during isolated cardiomyocyte contraction and decreased during relaxa-
tion [174]. Speciﬁc cardiac integrins (e.g.,α5-β1,αV-β3) are essential for
the heart's response to stress states and overall survival [176]. Integrin
β1 and FAK mediate mechanotransduction in the heart in response to
mechanical stretch. Integrin β1 also mediates the phosphorylation of
important intracellular MAP kinase signaling pathways including
phosphorylation of ERK, p38, and JNK following mechanical stretch of
neonatal rat ventricular myocytes. Inhibiting FAK activity reduced
resting and stretch-induced phosphorylation of ERK and integrin β1
was required for stretch-induced phosphorylation of FAK [177]. Integrin
β1may also be involved in age-relatedmyocardial stiffening and diastol-
ic diameter decrease [178].
Cell–cell interactions through cadherins have also been shown to be
important in the response of cardiomyocytes to changes in their
mechanical environment (Fig. 5). Matrices coated with N-cadherin
elicited changes in myoﬁbrillar organization, myocyte shape, and cell
stiffness, demonstrating the importance of cell–cell mediated force
perception via N-cadherin [173].
Mechanosensing molecules downstream from integrins and
cadherins in cardiac tissue (including FAK, vinculin, and catenins)
also play a role in cardiac remodeling, biomechanics, function, and
mechanotransduction. Mechanical stretching of cardiomyocytes
increased phosphorylation of FAK, migration of FAK from the
perinuclear region of neonatal rat ventricular myocytes to the myo-
ﬁlaments, and activation of the ANF gene [179]. Cyclical mechanical
stretch- induced FAK phosphorylation in rat cardiac ﬁbroblasts and
resulted in mTOR-dependent proliferation and activation of these
ﬁbroblasts into myoﬁbroblasts [180]. This ﬁbroblast activation to
myoﬁbroblast is believed to play a central role in adverse cardiac
ECM remodeling in response to stress states resulting in HF [139].
FAK signaling in response to mechanical pulsatile stretch is also
present in cardiomyocytes and involves MAPK and SPAK signaling
[181]. Cardiac-speciﬁc FAK knockout mice developed signiﬁcant
hypertrophy, increased LV mass, increased myocardial ﬁbrosis,
increased markers of ﬁbrosis, and increased collagen expression in
response to vasoconstrictor or transaortic constriction, two pressure
overload models [182]. Furthermore, isolation of cardiomyocytes
from these mice revealed disorganized myoﬁbrils and decreased
phosphorylation of p130Cas (docking protein involved in tyrosine-
kinase signaling in cell adhesion) and paxillin (protein contributing
to a focal adhesion), implicating these additional known
mechanosensing proteins in this process. The importance of FAK in
the cardiac remodeling response has also been demonstrated in a
model of pressure overload [183]. An important role for vinculin
in cardiac tissue and cardiomyocytes was demonstrated in cardiac-
speciﬁc vinculin knockout mice whereby loss of vinculin caused
abnormal myocardial biomechanics resulting in the development
of HF [184]. Additional molecules, such as β-catenin, mediate
the hypertrophic response of cardiomyocytes and the activation
response of cardiac ﬁbroblasts to myoﬁbroblasts during post-
infarct healing [185].
As mentioned above, a major source of increased stiffness in the
heart, in addition to the ECM compartment, is the cardiomyocyte
compartment. Studies demonstrated that the large intracellular cardio-
myocyte protein, titin, mediated diastolic biomechanics and acted as a
source of increased stiffness in HF (Fig. 5). Passive force occurs in the
myocardium during diastole and increases as the LV chamber expands
and ﬁlls [186]. Titin, located in the sarcomere of the cardiomyocyte, is
a major contributor to passive force and stiffness of the cardiomyocyte
during diastole [187]. Titin exists in various isoforms based on its phos-
phorylation status, and myocardium co-expresses varying amounts of
both isoforms. Cardiomyocytes from pigs expressing higher levels of
the N2BA isoform were less stiff compared to cardiomyocytes fromrats and mice that expressed higher levels of the N2B isoform [188].
Increased expression of the stiffer titin isoform has been demonstrated
in cardiomyocytes from failing myocardium [189]. Furthermore,
increased expression of a stiffer titin isoform has been demonstrated
in humanHFpEF, suggesting that a component of the increased diastolic
stiffness seen in HFpEF may be attributed to isoform expression shifts
favoring the increased expression of the stiffer titin isoform by
cardiomyocytes [166,190]. Therefore, therapeutic strategies targeting
abnormal cardiac biomechanics to treat HF may need to target both
ECM and cardiomyocyte tissue compartments.
Changes in the biomechanics and composition of myocardial tissue
have also been demonstrated during development whereby the
myocardial tissue and ECM become stiffer from the embryonic to
neonatal period through to adult periods. Optimum matrix stiffness is
required for neonatal cardiomyocytes to develop into structurally,
functionally, and biomechanically normal adult cardiomyocytes,
underscoring the importance of changes in cardiac biomechanics for
normal cardiovascular development [191–193].
3.5. Summary and future work
Therapies demonstrated to improve systolic function have improved
the outcomes of many subjects with HFrEF [143]. Unfortunately, no
therapeutic interventions in the HFpEF population have demonstrated
improved clinical outcomes [154]. Therefore, there is an urgent need
to further characterize the cardiac and extracardiac phenotypes of this
syndrome, identify and target novel risk factors, and propel the discov-
ery of new therapeutic interventions.
Since myocardial infarction results in scar formation at the infarct
site and deleterious remodeling in the infarct border zones and at
distant sites, prevention and attenuation of these mechanisms are of
clinical interest. To overcome these defects, valuable lessons may be
learned in the zebraﬁsh and newt since these animals regrow cardiac
tissues with no scar tissue [42,43]. Injection of human mesenchymal
stem cells into the acutely ischemic myocardium attenuated ﬁbrosis,
improved cardiac biomechanics, and reduced stiffness [170]. Further-
more, Drosophila may prove to be a powerful model for investigating
the molecular basis of age-related cardiomyopathy. LV diastolic
dysfunction is associated with aging [143], and senescent fruit ﬂies
experience decreased diastolic diameters, impaired myocardial relaxa-
tion, and increased myocardial stiffness, as measured in vivo by atomic
force microscopy [178,194]. Such a model is genetically tractable,
amenable to in vivo stiffness measurements, and recapitulates pheno-
types observed in higher mammals [195]. This phenotype is dependent
on integrin-linked kinase and β-integrin, implicating cell–ECM
adhesion as a novel therapeutic target [178].
4. Conclusions and future directions
This review integrates the essential mechanisms of
mechanotransduction underlying cell response to ECM dysfunction
in the context of injury and disease by examining two speciﬁc
cases, tendinopathy and HF. Tenocytes, TSCs, cardiomyocytes, and
cardiac ﬁbroblasts all sense ECM stiffness, one of the most profound
and well-studied mechanical properties inﬂuencing cell behavior,
using integrin-based adhesion complexes that couple the ECM to
the actin cytoskeleton.
Although the tendon and the heart are both soft tissues, they
demonstrate distinct composition, structure, and function in both
normal and diseased states. Tenocytes are present in lower cell densities
in the tendon than cardiomyocytes in the heart. In HF, the stiffening of
the heart tissue is a result of the production of ﬁbrotic ECM by
myoﬁbroblasts as well as the stiffening of cardiomyocytes themselves
in response to an altered microenvironment. Although the ECM in the
tendon also adapts, changes in tenocyte biomechanics during disease
progression remain unknown. The diseased state in tendinopathy is
3161B.R. Freedman et al. / Biochimica et Biophysica Acta 1853 (2015) 3153–3164decreased stiffening of the ECM, whereas the diseased state in HF is
increased stiffening.
Excessive loading from repetitive overuse activity causes TSCs to
differentiate into non-tenocyte lineages which produce aberrant ECM
components, further altering themechanical environment and perpetu-
ating the degeneration of native tendonproperties. In the case of cardiac
tissue, increased ECM stiffness causes ﬁbroblasts to differentiate into
myoﬁbroblasts, which produce more ECM components and stiffen the
local environment. Although the ECMs in the diseased tendon and
heart are reorganized in dramatically different ways in response to
their respective sources of disease onset, cells in these two tissues
respond to changes in the same ECM mechanical properties using
similar mechanotransduction machinery.
Despite this wealth of knowledge that highlights the central interac-
tion between the ECM and cell mechanotransduction, the current
treatments ameliorating dysfunctional ECM and cell mechanosensing
are limited. In addition to continued work using human and animal
model systems, additional knowledge may be gained from newt and
zebraﬁsh models that undergo unique ECM remodeling to regenerate
heart and limb tissues without scarring [196–200]. Given that altered
matrix stiffness often underlies tendinopathy and HF, understanding
how this remodeling supports regeneration biochemically and
mechanically may lead to novel therapeutic strategies for targeting
the dysfunctional ECM.Disclosures
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